276 related articles for article (PubMed ID: 26011295)
1. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination.
Williams RJ; Tse T; DiPiazza K; Zarin DA
PLoS One; 2015; 10(5):e0127242. PubMed ID: 26011295
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Frequency, Characteristics, and Reasons for Termination of Spine-related Clinical Trials.
Caruana DL; Nam-Woo Kim D; Galivanche AR; David WB; Justen MA; Moushey AM; Sheth AH; Paranjpe MD; Grauer JN
Clin Spine Surg; 2022 Aug; 35(7):E596-E600. PubMed ID: 35351841
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the frequency, characteristics, and reasons for termination of shoulder- and elbow-related clinical trials.
Caruana DL; Gouzoulis MJ; McLaughlin WM; Grauer JN
J Shoulder Elbow Surg; 2022 Sep; 31(9):1922-1928. PubMed ID: 35398166
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov.
Lebensburger JD; Hilliard LM; Pair LE; Oster R; Howard TH; Cutter GR
Clin Trials; 2015 Dec; 12(6):575-83. PubMed ID: 26085544
[TBL] [Abstract][Full Text] [Related]
5. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
6. Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006-2015.
Baldi I; Lanera C; Berchialla P; Gregori D
BMJ Open; 2017 Jun; 7(6):e013482. PubMed ID: 28619765
[TBL] [Abstract][Full Text] [Related]
7. Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
Khunger M; Rakshit S; Hernandez AV; Pasupuleti V; Glass K; Galsky MD; Grivas P
Oncologist; 2018 Dec; 23(12):1494-1499. PubMed ID: 30068783
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.
Bernardez-Pereira S; Lopes RD; Carrion MJ; Santucci EV; Soares RM; de Oliveira Abreu M; Laranjeira LN; Ikeoka DT; Zazula AD; Moreira FR; Cavalcanti AB; Mesquita ET; Peterson ED; Califf RM; Berwanger O;
Am Heart J; 2014 Aug; 168(2):213-9.e1. PubMed ID: 25066561
[TBL] [Abstract][Full Text] [Related]
9. Early Termination of Oncology Clinical Trials in the United States.
Zhang E; DuBois SG
Cancer Med; 2023 Mar; 12(5):5517-5525. PubMed ID: 36305832
[TBL] [Abstract][Full Text] [Related]
10. Estimating the rate and reasons of clinical trial failure in urologic oncology.
Stensland KD; DePorto K; Ryan J; Kaffenberger S; Reinstatler LS; Galsky M; Canes D; Skolarus TA; Moinzadeh A
Urol Oncol; 2021 Mar; 39(3):154-160. PubMed ID: 33257221
[TBL] [Abstract][Full Text] [Related]
11. Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types.
Buergy D; Riedel J; Sarria GR; Ehmann M; Scafa D; Grilli M; Wenz F; Hofheinz RD
Int J Cancer; 2021 Apr; 148(7):1676-1684. PubMed ID: 33045097
[TBL] [Abstract][Full Text] [Related]
12. Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials.
Guinn D; Wilhelm EE; Shoulson I
Ther Innov Regul Sci; 2020 Jan; 54(1):232-239. PubMed ID: 32008239
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Terminated Hand and Wrist-Related Clinical Trials.
Delma S; Foster BK; Baylor JL; Ozdag Y; Manzar S; Langford K; Klena JC; Grandizio LC
J Hand Surg Glob Online; 2023 Sep; 5(5):673-676. PubMed ID: 37790828
[TBL] [Abstract][Full Text] [Related]
14. Analysis of factors leading to early termination in glioblastoma-related clinical trials.
Shah HA; Mishra A; Gouzoulis MJ; Ben-Shalom N; D'Amico RS
J Neurooncol; 2022 Jul; 158(3):489-495. PubMed ID: 35648307
[TBL] [Abstract][Full Text] [Related]
15. A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis.
Kirkham JJ; Clarke M; Williamson PR
BMJ; 2017 May; 357():j2262. PubMed ID: 28515234
[No Abstract] [Full Text] [Related]
16. Reasons for and associated characteristics with early study termination: Analysis of ClinicalTrials.gov data on pregnancy topics.
Shieh C; Ofner S; Draucker CB
Nurs Outlook; 2022; 70(2):271-279. PubMed ID: 35090741
[TBL] [Abstract][Full Text] [Related]
17. Latent Dirichlet Allocation in predicting clinical trial terminations.
Geletta S; Follett L; Laugerman M
BMC Med Inform Decis Mak; 2019 Nov; 19(1):242. PubMed ID: 31775737
[TBL] [Abstract][Full Text] [Related]
18. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
19. Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis.
Jones CW; Safferman MR; Adams AC; Platts-Mills TF
BMJ Open; 2017 Oct; 7(10):e017719. PubMed ID: 29025842
[TBL] [Abstract][Full Text] [Related]
20. Results Reporting and Early Termination of Childhood Obesity Trials Registered on ClinicalTrials.gov.
Wang X; Long Y; Yang L; Huang J; Du L
Front Pediatr; 2022; 10():860610. PubMed ID: 35402346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]